vs

Side-by-side financial comparison of Pulmonx Corp (LUNG) and Strawberry Fields REIT, Inc. (STRW). Click either name above to swap in a different company.

Strawberry Fields REIT, Inc. is the larger business by last-quarter revenue ($40.1M vs $20.6M, roughly 1.9× Pulmonx Corp). Strawberry Fields REIT, Inc. runs the higher net margin — 5.0% vs -66.3%, a 71.4% gap on every dollar of revenue. On growth, Strawberry Fields REIT, Inc. posted the faster year-over-year revenue change (31.5% vs -8.7%). Over the past eight quarters, Strawberry Fields REIT, Inc.'s revenue compounded faster (20.0% CAGR vs -0.5%).

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

Strawberry Fields REIT, Inc. is a real estate investment trust focused on healthcare-related real estate assets. It owns, operates and manages skilled nursing facilities, senior living communities, and medical office buildings, primarily serving markets across the United States for healthcare providers and elderly care operators.

LUNG vs STRW — Head-to-Head

Bigger by revenue
STRW
STRW
1.9× larger
STRW
$40.1M
$20.6M
LUNG
Growing faster (revenue YoY)
STRW
STRW
+40.2% gap
STRW
31.5%
-8.7%
LUNG
Higher net margin
STRW
STRW
71.4% more per $
STRW
5.0%
-66.3%
LUNG
Faster 2-yr revenue CAGR
STRW
STRW
Annualised
STRW
20.0%
-0.5%
LUNG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LUNG
LUNG
STRW
STRW
Revenue
$20.6M
$40.1M
Net Profit
$-13.7M
$2.0M
Gross Margin
77.9%
Operating Margin
-40.9%
52.4%
Net Margin
-66.3%
5.0%
Revenue YoY
-8.7%
31.5%
Net Profit YoY
5.5%
37.6%
EPS (diluted)
$-0.33
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LUNG
LUNG
STRW
STRW
Q1 26
$20.6M
Q4 25
$22.6M
$40.1M
Q3 25
$21.5M
$39.7M
Q2 25
$23.9M
$37.9M
Q1 25
$22.5M
$37.3M
Q4 24
$23.8M
$30.5M
Q3 24
$20.4M
$29.5M
Q2 24
$20.8M
$29.3M
Net Profit
LUNG
LUNG
STRW
STRW
Q1 26
$-13.7M
Q4 25
$-10.4M
$2.0M
Q3 25
$-14.0M
$2.0M
Q2 25
$-15.2M
$2.0M
Q1 25
$-14.4M
$1.6M
Q4 24
$-13.2M
$1.5M
Q3 24
$-14.1M
$944.0K
Q2 24
$-15.3M
$938.0K
Gross Margin
LUNG
LUNG
STRW
STRW
Q1 26
77.9%
Q4 25
77.6%
Q3 25
74.7%
Q2 25
72.1%
Q1 25
72.5%
Q4 24
74.0%
Q3 24
73.7%
Q2 24
73.7%
Operating Margin
LUNG
LUNG
STRW
STRW
Q1 26
-40.9%
Q4 25
-43.8%
52.4%
Q3 25
-66.9%
56.6%
Q2 25
-62.0%
54.5%
Q1 25
-64.6%
54.1%
Q4 24
-56.5%
51.5%
Q3 24
-69.3%
54.4%
Q2 24
-75.2%
52.3%
Net Margin
LUNG
LUNG
STRW
STRW
Q1 26
-66.3%
Q4 25
-46.1%
5.0%
Q3 25
-64.9%
5.1%
Q2 25
-63.6%
5.2%
Q1 25
-64.1%
4.2%
Q4 24
-55.4%
4.8%
Q3 24
-69.4%
3.2%
Q2 24
-73.7%
3.2%
EPS (diluted)
LUNG
LUNG
STRW
STRW
Q1 26
$-0.33
Q4 25
$-0.25
$0.15
Q3 25
$-0.34
$0.16
Q2 25
$-0.38
$0.16
Q1 25
$-0.36
$0.13
Q4 24
$-0.33
$0.17
Q3 24
$-0.36
$0.14
Q2 24
$-0.39
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LUNG
LUNG
STRW
STRW
Cash + ST InvestmentsLiquidity on hand
$61.6M
$31.8M
Total DebtLower is stronger
$37.3M
$794.7M
Stockholders' EquityBook value
$45.8M
$12.1M
Total Assets
$120.0M
$885.2M
Debt / EquityLower = less leverage
0.82×
65.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LUNG
LUNG
STRW
STRW
Q1 26
$61.6M
Q4 25
$69.8M
$31.8M
Q3 25
$76.5M
$19.8M
Q2 25
$75.5M
$96.3M
Q1 25
$74.6M
$42.3M
Q4 24
$70.9M
$48.4M
Q3 24
$63.3M
$29.3M
Q2 24
$63.5M
$16.1M
Total Debt
LUNG
LUNG
STRW
STRW
Q1 26
$37.3M
Q4 25
$37.1M
$794.7M
Q3 25
$37.1M
$779.4M
Q2 25
$37.1M
$794.1M
Q1 25
$37.2M
$715.5M
Q4 24
$37.2M
$673.9M
Q3 24
$37.2M
$584.5M
Q2 24
$37.2M
$555.0M
Stockholders' Equity
LUNG
LUNG
STRW
STRW
Q1 26
$45.8M
Q4 25
$54.1M
$12.1M
Q3 25
$60.0M
$14.2M
Q2 25
$69.1M
$15.5M
Q1 25
$77.7M
$19.6M
Q4 24
$85.8M
$18.2M
Q3 24
$93.9M
$12.6M
Q2 24
$101.2M
$7.4M
Total Assets
LUNG
LUNG
STRW
STRW
Q1 26
$120.0M
Q4 25
$129.3M
$885.2M
Q3 25
$138.3M
$880.6M
Q2 25
$147.2M
$897.3M
Q1 25
$150.7M
$834.8M
Q4 24
$162.8M
$787.6M
Q3 24
$167.4M
$661.5M
Q2 24
$172.6M
$635.9M
Debt / Equity
LUNG
LUNG
STRW
STRW
Q1 26
0.82×
Q4 25
0.69×
65.64×
Q3 25
0.62×
54.70×
Q2 25
0.54×
51.26×
Q1 25
0.48×
36.47×
Q4 24
0.43×
37.09×
Q3 24
0.40×
46.34×
Q2 24
0.37×
74.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LUNG
LUNG
STRW
STRW
Operating Cash FlowLast quarter
$90.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
44.62×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LUNG
LUNG
STRW
STRW
Q1 26
Q4 25
$-7.1M
$90.0M
Q3 25
$-8.2M
$20.7M
Q2 25
$-3.9M
$29.8M
Q1 25
$-13.2M
$19.0M
Q4 24
$-6.7M
$59.3M
Q3 24
$-7.2M
$11.8M
Q2 24
$-5.8M
$20.6M
Free Cash Flow
LUNG
LUNG
STRW
STRW
Q1 26
Q4 25
$-7.1M
Q3 25
$-8.3M
Q2 25
$-4.0M
Q1 25
$-13.5M
Q4 24
$-6.8M
Q3 24
$-7.7M
Q2 24
$-6.2M
FCF Margin
LUNG
LUNG
STRW
STRW
Q1 26
Q4 25
-31.4%
Q3 25
-38.4%
Q2 25
-16.6%
Q1 25
-60.0%
Q4 24
-28.8%
Q3 24
-37.6%
Q2 24
-30.0%
Capex Intensity
LUNG
LUNG
STRW
STRW
Q1 26
Q4 25
0.1%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
1.3%
Q4 24
0.5%
Q3 24
2.0%
Q2 24
2.3%
Cash Conversion
LUNG
LUNG
STRW
STRW
Q1 26
Q4 25
44.62×
Q3 25
10.26×
Q2 25
15.24×
Q1 25
11.97×
Q4 24
40.44×
Q3 24
12.53×
Q2 24
21.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons